COMMUNIQUÉS West-GlobeNewswire

Stride Autism Centers Becomes First and Only ACQ-Accredited ABA Therapy Provider in South Dakota
06/10/2026
Milestone recognition from the Autism Commission on Quality highlights Stride’s commitment to clinical excellence, safety, and family-centered care for young children with autism SIOUX FALLS, S.D., Oct. 06, 2026 (GLOBE [...]
Ernexa Therapeutics’ ERNA-101 Selected for Flash Talk Presentation at Nature Conferences’ Next-Generation Cancer Therapeutics Meeting Co-Hosted by MD Anderson Cancer Center
06/10/2026
Preclinical data highlighting ERNA-101’s potential to activate the ovarian cancer tumor microenvironment and enhance checkpoint blockade will be presented October 6, 2026, at MD Anderson Cancer Center in Houston [...]
Dogwood to Participate in the 2026 Maxim Growth Summit
06/10/2026
ATLANTA, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a company that focuses on developing first-in-class, new non-opioid medicines to treat pain and neuropathy, today [...]
Spectral AI Submits New Technology Add-On Payment (NTAP) Application for DeepView™ System
06/10/2026
DALLAS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]
NeuroRPM Becomes an athenahealth Solution Partner, Now Available in the athenahealth Marketplace
06/10/2026
Bringing Reimbursable, Continuous Parkinson’s Monitoring into Clinical Workflows WASHINGTON, Oct. 06, 2026 (GLOBE NEWSWIRE) -- NeuroRPM, a provider of FDA-cleared, AI-enabled wearable technology for remote monitoring of [...]
Microbot Medical® and Medtechnica Ltd. Enter into Three-Year Exclusive Distribution Agreement in Israel
06/10/2026
Medtechnica Ltd., a Leading Medical Device Distributor in Israel, Authorized to Distribute the LIBERTY ® Endovascular Robotic System Throughout Israel Microbot Medical is Executing its International Markets Strategy by [...]
Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) Submission
06/10/2026
Company advances manufacturing scale-up, regulatory testing and preclinical work supporting its planned FDA 510(k) submission in the first quarter of 2027. Multiple scaled-up batches of CXU™ material met predefined [...]
Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026
06/10/2026
PRINCETON, N.J., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2026 financial results on Wednesday, [...]
HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device
06/10/2026
Southlake, TX, Oct. 06, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography [...]
Arcutis’ ZORYVE® (roflumilast) Wins 2026 Marie Claire Beauty Award
06/10/2026
Newly created award category highlights innovation in prescription skin treatment ZORYVE cream 0.15% for mild to moderate atopic dermatitis (eczema) in adults and children 6 years of age and older is first medication to [...]
60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA
06/10/2026
After a scheduled interim analysis of the severe babesiosis study on October 1, 2026, the DSMB recommended completing the study with the originally planned number of patients (N=33); the study remains blinded As of the [...]
API Innovation Center Launches the U.S.’ First Benchmark for Pharmaceutical Supply Chain Fragility
06/10/2026
More than 550 million prescriptions were filled for medicines with High or Severe supply-chain fragility, according to APIIC’s new national benchmark ST. LOUIS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- More than 550 million [...]
Hydrafacial Introduces HydraClear™ Treatment Booster to Clarify Blemish-Prone Skin
06/10/2026
New triple-acid treatment booster is designed to help clarify, balance, and fade visible signs of blemish-prone skin while helping maintain hydration LONG BEACH, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) -- SkinHealth [...]
Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026
06/10/2026
NORCROSS, Ga., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced participation in the upcoming AASLD Liver [...]
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
06/10/2026
CALGARY, Alberta, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Marvel Biosciences Corp. (TSXV: MRVL | OTCQB: MBCOF) , and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), a drug [...]
Nox Peptides Announces Launch of GHK-Cu and Wolverine Stack for Canadian Research Market
06/10/2026
TORONTO, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Nox Peptides today announced the launch of two research-focused peptide products, GHK-Cu and the Wolverine Stack , expanding its product offering for Canadian laboratories, [...]
Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
06/10/2026
Peer-Reviewed Paper Introduces QRX003 and Its Mechanism of Action in Netherton Syndrome Case Report Details Professor Alan Irvine’s Clinical Experience Treating a Pediatric Patient Under Quoin’s Compassionate Use [...]
First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)
06/10/2026
First doses of Pixclara administered in Cleveland (OH) and Indianapolis (IN) marking the start of U.S. commercial availability. Pixclara is the only FDA-approved radiopharmaceutical imaging drug for glioma (brain cancer [...]
MediciNova to Participate in the Maxim Growth Summit
06/10/2026
LA JOLLA, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

Pages